Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia
Condition(s):Angioplasty; Critical Lower Limb IschemiaLast Updated:November 14, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Angioplasty; Critical Lower Limb IschemiaLast Updated:November 14, 2023Active, not recruiting
Condition(s):Soft Tissue Sarcoma; Bone SarcomaLast Updated:January 3, 2024Recruiting
Condition(s):Peripheral Arterial DiseaseLast Updated:January 31, 2022Completed
Condition(s):Peripheral Artery Disease (PAD)Last Updated:January 26, 2023Completed
Condition(s):Diabetic Foot Ulcer; AmputationLast Updated:July 13, 2010Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:January 24, 2024Completed
Condition(s):Diabetes MellitusLast Updated:March 13, 2024Not yet recruiting
Condition(s):Critical Limb IschemiaLast Updated:July 23, 2021Unknown status
Condition(s):Critical Limb IschemiaLast Updated:October 27, 2021Completed
Condition(s):Osteosarcoma in ChildrenLast Updated:April 3, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.